$iova Here’s what’s coming fast: Australian approval decision European resubmission for approval TILVANCE-301 early readout (forthcoming) 4001 data readout 5001 trial initiation The big one: NSCLC sBLA submission + additional data presentations Sub 2B market cap. Hilarious